Skip to main content
. 2014 Mar 21;10(4):415–425. doi: 10.7150/ijbs.8002

Figure 6.

Figure 6

Antitumor effects of miR-214 in vivo. The hepatoma-bearing mice were treated with negative control oligonucleotide (group 5), miR-214 inhibitor (group 6), NCTD + negative control (group 7) and NCTD + miR-214 inhibitor (group 8). (A) Tumor sizes on each mouse were monitored 2 times per week and (B) tumor weights were measured. *P < 0.05, indicate significant differences from group 5. #P < 0.05, indicate significant differences from group 7. (C) The expression of miR-214 was detected in TAMs from group 7 and group 8. *P < 0.05, indicate significant differences from group 7.